Hear at Last Signs a Canada Wide Distribution with Hohm Pods for Portable Home Pods
Toronto, Ontario--(Newsfile Corp. - November 7, 2024) - HearAtLast Holdings, Inc. (OTC Pink: HRAL), is excited to work with Hohm...
Toronto, Ontario--(Newsfile Corp. - November 7, 2024) - HearAtLast Holdings, Inc. (OTC Pink: HRAL), is excited to work with Hohm...
Alcaraz brings nearly 20 years of experience in quality management to the roleWest Caldwell, New Jersey--(Newsfile Corp. - November 7,...
Common Shares to Begin Trading on Nasdaq on Tuesday, November 12, 2024Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November...
Vancouver, British Columbia--(Newsfile Corp. - November 7, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company...
Halifax, Nova Scotia--(Newsfile Corp. - November 7, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is...
Final step before the full launch of breast cancer screening program, Revealia™SPARKS, NV / ACCESSWIRE / November 7, 2024 /...
Revenue increased 31% for the quarter compared to same period prior yearPositive cash flows from operations of $0.35 million for...
Leading Organic Trade Organization Lists Nature-Cide All-Purpose Commercial Concentrate as Allowed for the Use in Accordance with the National Organic...
Company Achieves Milestones in Both Clinical ProgramsInitiates Mipletamig Phase 1b/2 Clinical Trial, "RAINIER," in Frontline Acute Myeloid Leukemia, Informed by...
The global cannabis market size was valued at USD 43.72 billion in 2022 and is projected to grow from USD...
-Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid...
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / November 7, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company...
Split Becomes Effective Monday, November 11, 2024Shareholder- and Board-Approved Action Reduces Shares Outstanding to 313,235 from 31 Million, Ensures Continued...
Reports third quarter revenues of $1.9 billion, GAAP net income of $13 million and GAAP EPS of $0.03Achieves year-to-date product...
WEDEL, Germany, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Testing new substances in animals is a regulatory cornerstone of drug development....
MB-108 (HSV-1 oncolytic virus) is active and well tolerated in patients with recurrent glioblastoma in ongoing Phase 1 clinical trial...
Conference Call Scheduled for Thursday, November 14, 2024 at 9:00 AM ETPORTLAND, Maine, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ImmuCell...
Partnerships will employ Vaccinex’s ActivMAb® platform for viral display of complex antigens to enable antibody discoveryROCHESTER, N.Y., Nov. 07, 2024...
Financials for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 will be released on Thursday, November 14,...
For the quarter ended September 30, 2024: Total Revenue of $2.4 billion, a 68% increase year-over-year Medical Loss Ratio of...